Delivery Order SPE2DB22D3501-SPE2DB24FWB91

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply Trulicity 3 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price of $2,267.68 and a completion date of June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity (3 mg/0.5 ml) pens. The contract is a Delivery Order valued at $1,741.68 with a firm fixed price. The contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 3 mg/0.5 ml pens. The contract has a ceiling value of $1,741.68 and runs through July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a broad range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide Trulicity 3 mg/0.5 ml pens. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,902.80 and a completion date of July 15, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract, valued at $1,451.40, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 3 mg/0.5 ml pens. The $13,289.22 firm fixed price delivery order has a completion date of September 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This federal contract award, valued at $1,824.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 3 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price pricing type and a completion date of September 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Trulicity 3 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price of $7,002.60 and an Ultimate Completion Date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of Trulicity 3 mg/0.5 ml pens. The $1,741.68 firm fixed-price contract runs through July 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 3 mg/0.5 ml pens. The contract has a ceiling value of $3,437.52 and is a firm fixed-price delivery order with a period of performance through February 16, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWB91
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Trulicity 3 mg/0.5 mL pens. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,015.98 and a completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation.

Generated 9/24/24, 9:36 AM